Pharmaceutical composition for effectively preventing and treating cardiovascular and cerebrovascular diseases

Abstract

The invention discloses a pharmaceutical composition for effectively preventing and treating occurrence and development of cardiovascular and cerebrovascular diseases. The composition is mainly composed of the following substances in parts by weight: 0.5-50 parts of ligustrazine, 1-90 parts of berberine, 0.8-80 parts of a folium ginkgo extract, 0.25-25 parts of tea polyphenols, 0.5-50 parts of black fungus polysaccharide, 0.0005-0.05 part of hirudin, and 0.0005-0.05 part of selenium. The main dosage form of the pharmaceutical composition is an oral preparation prepared by the composition according to a conventional pharmaceutical method of pharmacy. Many key pathological links of vascular endothelial inflammatory injury caused by atherosclerosis, dyslipidemia, platelet aggregation and freeradicals can be comprehensively solved, and a more scientific, more comprehensive, safer, more effective and more natural new prevention and treatment method is provided for people for prevention andtreatment of cardiovascular and cerebrovascular diseases; the use amount of chemical drugs and the toxic and side effects of the chemical drugs can be replaced or reduced, and the pharmaceutical composition is an upgraded supplement and high-quality substitute for natural drugs.

Description

technical field [0001] The invention relates to the field of medical treatment and prevention, in particular to a pharmaceutical composition for preventing and treating cardiovascular and cerebrovascular diseases. Background technique [0002] Cardiovascular and cerebrovascular diseases are the leading cause of human death. Cardiovascular and cerebrovascular diseases are mainly composed of thrombotic infarction and hemorrhagic infarction. Scientific research has shown that the pathological process of the occurrence and development of cardiovascular and cerebrovascular diseases has a close causal relationship with human atherosclerosis, the thickening and brittleness of the vessel wall, the formation of lipid plaques, the aggregation of platelets to form thrombus, and the narrowing of the lumen. The main environmental factors that accelerate atherosclerosis, brittleness, stenosis and lipid plaque formation and activation of platelet coagulation mechanism are: 1. Long-term dy...

AI Technical Summary

Problems solved by technology

[0003] Cardiovascular and cerebrovascular diseases are the main diseases that cause disability, paralysis, and death to the human body. At present, our prevention and treatment methods are mainly manifested in the following aspects: 1. Emphasis on treatment rather than prevention; Disabling rate, fatality rate and reducing the degree of disability are medical goals, neglecting the prevention and development of diseases, and lack of comprehensive and effective prevention and treatment methods, which makes the incidence of cardiovascular and cerebrovascular diseases in our society, disability rate, High case fatality rate

2. The therapy is single; most of them are lipid-lowering, blood vessel expansion, anticoagulant and other products, but the problem has not been solved from the multi-factors of the source of cardiovascular and cerebrovascular diseases. Prevention and treatment measures of vascular disease occurrence and development

Images